Pharmacoeconomic evaluation of COPD

Stratification of outcomes and costs according to initial drug therapy

Daniel E. Hilleman, E. C. Wadibia, B. Shinn

Research output: Contribution to journal › Article

Abstract

Introduction: The outcomes and treatment costs of a cohort of 355 patients (pts) with COPD were evaluated. Methods: Pts with moderate to severe (predicted FEV,

Original languageEnglish
JournalChest
Volume110
Issue number4 SUPPL.
StatePublished - Oct 1996

Fingerprint

Pharmaceutical Economics
Health Care Costs
Chronic Obstructive Pulmonary Disease
Costs and Cost Analysis
Drug Therapy

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine

Cite this

Pharmacoeconomic evaluation of COPD : Stratification of outcomes and costs according to initial drug therapy. / Hilleman, Daniel E.; Wadibia, E. C.; Shinn, B.

In: Chest, Vol. 110, No. 4 SUPPL., 10.1996.

Research output: Contribution to journal › Article

Hilleman, DE, Wadibia, EC & Shinn, B 1996, 'Pharmacoeconomic evaluation of COPD: Stratification of outcomes and costs according to initial drug therapy', Chest, vol. 110, no. 4 SUPPL..
Hilleman DE, Wadibia EC, Shinn B. Pharmacoeconomic evaluation of COPD: Stratification of outcomes and costs according to initial drug therapy. Chest. 1996 Oct;110(4 SUPPL.).
Hilleman, Daniel E. ; Wadibia, E. C. ; Shinn, B. / Pharmacoeconomic evaluation of COPD : Stratification of outcomes and costs according to initial drug therapy. In: Chest. 1996 ; Vol. 110, No. 4 SUPPL.
@article{0725d5c06ca44983a58747895b0281d7,
title = "Pharmacoeconomic evaluation of COPD: Stratification of outcomes and costs according to initial drug therapy",
abstract = "Introduction: The outcomes and treatment costs of a cohort of 355 patients (pts) with COPD were evaluated. Methods: Pts with moderate to severe (predicted FEV,",
author = "Hilleman, {Daniel E.} and Wadibia, {E. C.} and B. Shinn",
year = "1996",
month = "10",
language = "English",
volume = "110",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "4 SUPPL.",

}

TY - JOUR

T1 - Pharmacoeconomic evaluation of COPD

T2 - Stratification of outcomes and costs according to initial drug therapy

AU - Hilleman, Daniel E.

AU - Wadibia, E. C.

AU - Shinn, B.

PY - 1996/10

Y1 - 1996/10

N2 - Introduction: The outcomes and treatment costs of a cohort of 355 patients (pts) with COPD were evaluated. Methods: Pts with moderate to severe (predicted FEV,

AB - Introduction: The outcomes and treatment costs of a cohort of 355 patients (pts) with COPD were evaluated. Methods: Pts with moderate to severe (predicted FEV,

UR - http://www.scopus.com/inward/record.url?scp=33746398668&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746398668&partnerID=8YFLogxK

M3 - Article

VL - 110

JO - Chest

JF - Chest

SN - 0012-3692

IS - 4 SUPPL.

ER -

Access to Document